Latest news
REMS Programs for BCMA-Directed Therapies: Background, Best Practices, and Institutional Protocols - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMTAdverse Event Management for Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMT340B's Next Era: Why Hospitals Must Pair Compliance With Measurable Quality Outcomes - Pharmacy TimesPharmacy Times · Wed, 05 Aug 2026 16:07:04 GMTCervical Cancer Screening and HPV Self-Collection: What Pharmacists Want Patients to Know - Pharmacy TimesPharmacy Times · Tue, 04 Aug 2026 16:26:38 GMT